Evidence map›Paper›PMID 32400924›Full record

ArticlePediatric blood & cancer2020

The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global.

Michael Sullivan, Eric Bouffet, Carlos Rodriguez-Galindo, Sandra Luna-Fineman, Muhammad Saghir Khan, Pam Kearns, Douglas S Hawkins, Julia Challinor, Lisa Morrissey, Jörg Fuchs and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 8 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 8 syntheses or guidelines pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Guideline
  8. Pooled it
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 18 institutions in 10 countries.

Michael SullivanChildren's Cancer Centre, Royal Children's Hospital and Department of Paediatrics, Faculty of Medicine Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.ORCID https://orcid.org/0000-0002-8606-5889
Eric BouffetDivision of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-6832-6539
Carlos Rodriguez-GalindoDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.ORCID https://orcid.org/0000-0002-2360-8946
Sandra Luna-FinemanHematology/Oncology/SCT Children's Hospital Colorado, University of Colorado, Aurora, Colorado.ORCID https://orcid.org/0000-0003-0713-7651
Muhammad Saghir KhanPediatric Hematology Oncology, Tawam Hospital, Al Ain Abu Dhabi, United Arab Emirates.
Pam KearnsBirmingham Children's Hospital and Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
Douglas S HawkinsPediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, Washington.
Julia ChallinorSchool of Nursing, University of California San Francisco, San Francisco, California.
Lisa MorrisseyDivision of Nursing, Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.ORCID https://orcid.org/0000-0001-5524-203X
Jörg FuchsDepartment of Pediatric Surgery Children's Hospital, University of Tuebingen, Tuebingen, Germany.
Karen MarcusDana-Farber/Boston Children's Cancer and Blood Disorders Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Adriana BalduzziPaediatric Department, MBBM Foundation, ASST Monza Ospedale San Gerardo, University of Milano Bicocca, Monza, Italy.
Luisa Basset-SalomChildhood Cancer International (www.childhoodcancerinternational.org) and International representative of Fed, Española de Padres de NIÑOS CON Cáncer (www.cancerinfantil.org), Madrid, Spain.
Miguela CanizaDepartments of Global Pediatric Medicine and Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.
Justin N BakerDivision of Quality of Life and Palliative Care, Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Rejin KebudiPediatric Hematology Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-4344-8174
Laila HessissenPediatric Hematology and Oncology, Mohammed V University of Rabat, Rabat, Morocco.ORCID https://orcid.org/0000-0002-3322-273X
Richard SullivanSchool of Cancer Science, King's College London, UK, Institute of Cancer Policy and Conflict and Health Research Group, and Research for Health Care in Conflict (https://r4hc-mena.org/), London, UK.
Kathy Pritchard-JonesInternational Society of Paediatric Oncology (SIOP), UCL Great Ormond Street Institute of Child Health, University College London, London, UK.ORCID https://orcid.org/0000-0002-2384-9475
Contributing Authors
St. Jude Children's Research Hospital · USBirmingham Children's Hospital · GBBoston Children's Hospital · USBrigham and Women's Hospital · USChildren's Hospital Colorado · USFederación Española de Padres de Niños con Cáncer · ESHospital for Sick Children · CAIstanbul University · TRKing's College London · GBMohammed V University · MARoyal Children's Hospital · AUSeattle Children's Hospital · USTawam Hospital · AEThe Dialogue · USUniversity Children's Hospital Tübingen · DEUniversity College London · GBUniversity of California, San Francisco · USUniversity of Milano-Bicocca · IT

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Cancer Research UK 28028NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899
6 · The paper itself

Abstract

The COVID-19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades. This Special Report aims to summarize general principles for continuing multidisciplinary care during the SARS-CoV-2 (COVID-19) pandemic. With contributions from the leadership of the International Society for Pediatric Oncology (SIOP), Children's Oncology Group (COG), St Jude Global program, and Childhood Cancer International, we have sought to provide a framework for healthcare teams caring for children with cancer during the pandemic. We anticipate the burden will fall particularly heavily on children, their families, and cancer services in low- and middle-income countries. Therefore, we have brought together the relevant clinical leads from SIOP Europe, COG, and SIOP-PODC (Pediatric Oncology in Developing Countries) to focus on the six most curable cancers that are part of the WHO Global Initiative in Childhood Cancer. We provide some practical advice for adapting diagnostic and treatment protocols for children with cancer during the pandemic, the measures taken to contain it (e.g., extreme social distancing), and how to prepare for the anticipated recovery period.

Indexed as

Disease ManagementBetacoronavirusChildConsensusCoronavirus InfectionsCOVID-19HumansMedical OncologyNeoplasmsPandemicsPediatricsPneumonia, ViralSARS-CoV-2Societies, Medicalacute lymphoblastic leukemiaBurkitt lymphomachildhood cancerCOVID-19Hodgkin lymphomalow-grade gliomanephroblastomapediatricsretinoblastomaSARS-CoV-2WHO Global Initiative on Childhood CancerWilms tumor

Identifiers

PMID32400924
PMCPMC7235469
OpenAlexW3025633253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.